Skip to main content
Clinical Trials/NCT05930873
NCT05930873
Recruiting
N/A

Evaluating the Effect of Immersive Room Intervention on Visual Attention in Children With Autism Spectrum Disorders

Istituto per la Ricerca e l'Innovazione Biomedica1 site in 1 country30 target enrollmentJune 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Istituto per la Ricerca e l'Innovazione Biomedica
Enrollment
30
Locations
1
Primary Endpoint
Wechsler Intelligence Scale for Children Fourth edition (WISC-IV)
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Autism spectrum disorder (ASD) is a common neurodevelopmental disorder characterized by language delay, impaired social interactions, and repetitive behaviors. Its manifestation varies among individuals due to genetic and environmental factors. Technology-based interventions, such as robots, serious games, virtual reality and immersive room, have shown better results in the cognitive-behavioral treatment of ASD. Visual attention, which is often deficient in individuals with ASD, is a focus in these interventions, as it can aid stimulus processing. Virtual reality offers a more ecological environment for such interventions.

In this study, it has been demonstrated the effectiveness of virtual reality training by comparing the performance of an ASD group delivering treatment through the immersive room with a control group delivering traditional treatment.

Fifteen children with ASD between the ages of 5 and 10 years, with IQs between 55 and 85 will be included in the trial and, following an assessment related to visual attention processes, will be randomly assigned to the control group and the experimental group. The trial participants will, first, undergo structured sessions to foster or increase the receptive area related to the stimuli to which they will be subjected during the training.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
April 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Istituto per la Ricerca e l'Innovazione Biomedica
Responsible Party
Principal Investigator
Principal Investigator

Flavia Marino

Head of Unit

Istituto per la Ricerca e l'Innovazione Biomedica

Eligibility Criteria

Inclusion Criteria

  • Child with diagnosis of autism

Exclusion Criteria

  • presence of other medical disorders

Outcomes

Primary Outcomes

Wechsler Intelligence Scale for Children Fourth edition (WISC-IV)

Time Frame: The evaluation session will be scheduled pre-intervention. The test needs approximately 65-80 minutes to complete.

Wechsler Intelligence Scale for Children Fourth edition (WISC-IV) is a clinical tool for assessing the cognitive abilities of children and young people between the ages of 6 years and 16 years and 11 months.

NEPSY-II

Time Frame: The evaluation sessions will be scheduled pre and post intervention.The test needs approximately 90 minutes to complete for preschool children and 120-180 minutes for school-age children

NEPSY-II is the most internationally known battery for assessing neuropsychological development in developmental age.

Study Sites (1)

Loading locations...

Similar Trials